Daniel Deykin
Daniel Deykin publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Surgery, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management and Eicosanoids and Hypertension Pharmacology.
- World rank
- #105,231 of 7,710,434 ranked researchers
- Rank in United States
- #40,228 of 1,627,098
- Works
- 186
- Citations
- 15k
- Citations per work
- 81.6
What does Daniel Deykin research?
Daniel Deykin's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else9249.5%
- Health Sciences8042.9%
- Medicine8042.9%
- Life Sciences147.6%
- 1Cardiology and Cardiovascular Medicine12% of their works
- 2Hematology11% of their works
- 3Surgery9% of their works
- 4Molecular Biology8% of their works
- 5Internal Medicine6% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Eicosanoids and Hypertension Pharmacology
- Atrial Fibrillation Management and Outcomes
- Platelet Disorders and Treatments
- Inflammatory mediators and NSAID effects
- Blood properties and coagulation
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Daniel Deykin's research?
The keywords of their largest research topics: Inflammation, Diagnosis, Hemostasis, Thrombosis, Aspirin, Clopidogrel, Antithrombotic Therapy and Venous Thromboembolism.
- Vaccination
- Heparin-Induced Thrombocytopenia
- Cyclooxygenase-2 Inhibitors
- Platelets
- Atrial Fibrillation
- Epoxyeicosatrienoic Acids
- Venous Thromboembolism
- Clopidogrel
- Thrombosis
- Diagnosis
- Inflammation
- Hemostasis
- Aspirin
- Antithrombotic Therapy
- Arachidonic Acid
- Anticoagulant Therapy
- Immune Thrombocytopenic Purpura
- Cancer
- Fibrinogen
- Transglutaminases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Inflammation643 topics
- Diagnosis462 topics
- Hemostasis382 topics
- Thrombosis382 topics
- Aspirin361 topic
- Clopidogrel361 topic
- Antithrombotic Therapy291 topic
- Venous Thromboembolism291 topic
- Arachidonic Acid251 topic
- Epoxyeicosatrienoic Acids251 topic
- Anticoagulant Therapy221 topic
- Atrial Fibrillation221 topic
- Immune Thrombocytopenic Purpura211 topic
- Platelets211 topic
- Cancer181 topic
- Cyclooxygenase-2 Inhibitors181 topic
- Fibrinogen171 topic
- Heparin-Induced Thrombocytopenia171 topic
- Transglutaminases171 topic
- Vaccination171 topic
Where does Daniel Deykin work?
Daniel Deykin's main affiliation in the publication record is Boston Medical Center, United States.
How many publications and citations does Daniel Deykin have?
OpenAlex counts 186 works and 15,180 citations for Daniel Deykin, an h-index of 59, ranking #105,231 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel Deykin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.